Overall survival (OS) implications for patients with mCRPC through coverage and adoption of nuclear AR-V7 testing by healthcare systems Meeting Abstract
| Authors: | Hornberger, J.; Graf, R. P.; Hulling, M.; Attard, G.; Allan, A.; Dittamore, R.; Scher, H. I. |
| Abstract Title: | Overall survival (OS) implications for patients with mCRPC through coverage and adoption of nuclear AR-V7 testing by healthcare systems |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy284.057 |
| Language: | English |
| ACCESSION: | WOS:000459277302030 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy284.057 |
| Notes: | Meeting Abstract: 848P -- Appears on pages viii296-viii297 of the abstract book -- M. Hullings's last name is misspelled on the original publication -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
